Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Total Liabilities (2016 - 2026)

Orthofix Medical has reported Total Liabilities over the past 18 years, most recently at $451.4 million for Q1 2026.

  • For the quarter ending Q1 2026, Total Liabilities rose 23.73% year-over-year to $451.4 million, compared with a TTM value of $451.4 million through Mar 2026, up 23.73%, and an annual FY2025 reading of $400.6 million, up 2.68% over the prior year.
  • Total Liabilities came in at $451.4 million for Q1 2026, up from $400.6 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $451.4 million in Q1 2026 to a low of $116.1 million in Q3 2022.
  • Median Total Liabilities over the past 5 years was $335.7 million (2024), compared with a mean of $294.4 million.
  • The sharpest move saw Total Liabilities fell 20.52% in 2022, then skyrocketed 168.2% in 2023.
  • Over 5 years, Total Liabilities stood at $121.8 million in 2022, then skyrocketed by 168.2% to $326.6 million in 2023, then increased by 19.47% to $390.2 million in 2024, then rose by 2.68% to $400.6 million in 2025, then rose by 12.68% to $451.4 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Total Liabilities are $451.4 million (Q1 2026), $400.6 million (Q4 2025), and $390.1 million (Q3 2025).